Quality Management System in Pharmaceuticals: Principles, Practice, and Modernization

Quality Management Systems (QMS) in the pharmaceutical industry establish the structured policies, procedures, and defined responsibilities required to maintain consistent product quality, safety, and efficacy throughout the entire product lifecycle. This review integrates the foundational regulatory expectations outlined in current Good Manufacturing Practices (cGMP), including FDA 21 CFR Parts 210, 211, and 11, alongside EU GMP Annex 11. It further incorporates the harmonized framework of ICH Q10, supported by Quality Risk Management and Knowledge Management, as well as recognized industry standards such as ISO 9001:2015 and ISPE GAMP 5. Key elements of an effective Pharmaceutical Quality System (PQS)—process performance and product quality monitoring, corrective and preventive actions (CAPA), change management, and management review—are examined in depth. Additional focus is placed on operationalizing QMS principles through robust data integrity practices, supplier and outsourced activity oversight, and the progressive transition from paper‑based or hybrid models to integrated electronic QMS (eQMS) platforms. The review also proposes a practical maturity pathway and identifies meaningful quality key performance indicators (KPIs) applicable to commercial manufacturing environments, supporting continual improvement and long‑term inspection readiness.